Carfilzomib for previously treated multiple myeloma

Final draft guidance: TA657

Final appraisal document - TA657 (PDF 333 KB)

Stakeholder matrix - TA657 (PDF 160 KB)

Review proposal paper (2) - TA657 (PDF 189 KB)

Stakeholder matrix (2) - TA657 (PDF 160 KB)

Review proposal paper (1) - TA657 (PDF 264 KB)

Stakeholder matrix (1) - TA657 (PDF 261 KB)

Equality Impact Assessment (Guidance development) - TA457 (PDF 248 KB)

Final appraisal document - TA457 (PDF 539 KB)

Committee papers - TA457 (PDF 6.63 MB)

Public committee slides - TA457 (PDF 355 KB)

Appraisal consultation document (PDF version) - TA457 (PDF 414 KB)

Final scope - TA457 (PDF 107 KB)

Final stakeholder list - TA457 (PDF 99 KB)

NICE's response to comments on the draft scope and provisional stakeholder list - TA457 (PDF 159 KB)

Equality impact assessment (Scoping) - TA457 (PDF 121 KB)

Draft scope post referral - TA457 (PDF 112 KB)

Draft matrix post referral - TA457 (PDF 99 KB)